Investment & Asset Management Analyst

Undertake research and analysis to identify new product opportunities in Emerging Markets and provide insights to support the Portfolio Selection Committee's decisions and Portfolio Strategy Planning, aligning with MSN Labs' growth objectives. Roles and Responsibilities : Identify new product / molecule opportunities across therapies in the small molecules’ space basis the medical and marketing feasibility. Conduct in-depth analysis of secondary market data to understand opportunities available across therapies Preliminary IP landscaping of products with respect to various patents across the globe. Build and update business case for new products proposed for selection in the portfolio selection meeting. Constantly track the market updates like label expansions, competition entry, safety warnings, quarterly sales for innovator brands, API supplieretc.) for the selected products Constantly conduct competitor analysis to remain abreast of market trends. Identify new entry channels for the company through in-licensing and other opportunities, in order to drive the business growth Mandatory skills : Strong understanding of IP landscape in pharma across the markets Good understanding of pharma regulatory of at least US, EU and Emerging markets Good understanding of Formulation selection process such as understanding the medical uniqueness, commercial forecast, and fitment with MSN technical capabilities. Good understanding of forecasting, patient funneling and pricing strategy. Good understanding of data platforms such as IQVIA, Corelli's, IPD analytics, Global data Good communication and stakeholder management skills Strong analytical skills with command in Excel and PowerPoint Education Qualification : M. Pharm / M.Sc Chemistry / MBA (preferably from Tier I Institute / University) Work Experience : 3 to 5 years in Portfolio, Strategy and / or IPM